Camson Bio Technologies (Camson), India’s leading IPR-driven biotechnology company, has inked a Memorandum of Understanding (MoU) with the Coconut Development Board (CDB), a Ministry of Agriculture, Government of India enterprise, to develop non-chemical, zero-residue, secondary metabolite based biocides to control red palm weevil (Ryhnchophorus ferrugineus) infesting coconut plantations. Coconut Development Board has agreed to pay Camson Rs 25 lakh as its contribution towards the research.
Camson is the only company in the country with the requisite research experience and execution skills. Camson has been partnered under the board’s scheme ‘Technology Mission of Coconut’ to conduct research over a period spanning two years.
Camson Bio Technologies combines the latest knowledge in breeding, molecular genetics and metagenomics in agriculture with the latest practices in environmental safety and protection, to market a wide range of products spanning hybrid seeds, bio-fertilizers and biocides.
| Company Name | CMP |
|---|---|
| Venkys India | 1589.25 |
| Mangalam Global Ent | 12.93 |
| Kaveri Seed | 924.50 |
| Regaal Resources | 85.04 |
| Simran Farms | 165.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: